Resumen:
Ethnopharmacological relevance: The genus Hedyosmum (family: Chloranthaceae) represents an interesting source
of natural active compounds, and the 45 species of this genus are widespread in Central and South America and
to a lesser extent Southeast Asia (southern China and western Malaysia). Several species are traditionally used in
folk medicine. However, the data made available in recent years have not been organized and compared.
Aim of this review: The present study is a critical assessment of the state-of-the-art concerning the traditional
uses, the phytochemistry and the pharmacology of species belonging to the genus Hedyosmum to suggest further
research strategies and to facilitate the exploitation of the therapeutic potential of Hedyosmum species for the
treatment of human disorders.
Materials and methods: The present review consists of a systematic overview of scientific literature concerning
the genus Hedyosmum published between 1965 and 2018. Moreover, an older text, dated from 1843, concerning
the traditional uses of H. bonplandianum Kunth has also been considered. Several databases (Francis & Taylor,
Google Scholar, PubMed, SciELO, SciFinder, Springer, Wiley, and The Plant List Database) have been used to
perform this work.
Results: Sixteen species of the genus Hedyosmum have been mentioned as traditional remedies, and a large
number of ethnomedicinal uses, including for the treatment of pain, depression, migraine, stomach-ache and
ovary diseases, have been reported. Five species have been used as flavouring agents, tea substitutes or foods.
Sesterterpenes, sesquiterpene lactones, monoterpenes, hydroxycinnamic acid derivatives, flavonoids, and neolignans
have been reported as the most important compounds in these species. Studies concerning their biological
activities have shown that members of the Hedyosmum genus possesses promising biological properties,
such as analgesic, antinociceptive, antidepressant, anxiolytic, sedative, and hypnotic effects. Preliminary studies
concerning the antibacterial, antioxidant, antiplasmodial, and antifungal activities of these plants as well as their
cytotoxic activities against different tumour cell lines have been reported. Some active compounds from the
Hedyosmum genus have been used as starting points for the innovative and bioinspired development of synthetic
molecules. A critical assessment of these papers has been performed, and some conceptual and methodological
problems have been identified regarding the materials and methods and the experimental design used in these
studies, including a lack of ethnopharmacological research.
Conclusions: The present review partially confirms the basis for some of the traditional uses of Hedyosmum
species (mainly H. brasiliense) through preclinical studies that demonstrated their antinociceptive and neuroprotective
effects. Due to promising preliminary results, further studies should be conducted on 13-hydroxy-8,9-
dehydroshizukanolide and podoandin. Moreover, several essential oils (EOs) from this genus have been preliminarily investigated, and the cytotoxic and antibacterial activities of H. brasiliense and H. sprucei EOs certainly deserve further investigation. From the promising findings of the present analysis, we can affirm that this genus deserves further research from ethnopharmacological and toxicological perspectives.